全文获取类型
收费全文 | 705878篇 |
免费 | 48793篇 |
国内免费 | 1304篇 |
学科分类
医药卫生 | 755975篇 |
出版年
2019年 | 5430篇 |
2018年 | 7857篇 |
2017年 | 6106篇 |
2016年 | 6818篇 |
2015年 | 7550篇 |
2014年 | 10262篇 |
2013年 | 15380篇 |
2012年 | 20491篇 |
2011年 | 21485篇 |
2010年 | 12716篇 |
2009年 | 11928篇 |
2008年 | 19984篇 |
2007年 | 21503篇 |
2006年 | 21895篇 |
2005年 | 20435篇 |
2004年 | 19984篇 |
2003年 | 18939篇 |
2002年 | 18451篇 |
2001年 | 36327篇 |
2000年 | 36896篇 |
1999年 | 30379篇 |
1998年 | 7876篇 |
1997年 | 6663篇 |
1996年 | 6969篇 |
1995年 | 6632篇 |
1994年 | 6100篇 |
1993年 | 5589篇 |
1992年 | 22969篇 |
1991年 | 22927篇 |
1990年 | 22310篇 |
1989年 | 22076篇 |
1988年 | 20037篇 |
1987年 | 19419篇 |
1986年 | 18467篇 |
1985年 | 17305篇 |
1984年 | 12697篇 |
1983年 | 10741篇 |
1982年 | 5921篇 |
1979年 | 11518篇 |
1978年 | 8128篇 |
1977年 | 6832篇 |
1976年 | 6594篇 |
1975年 | 7268篇 |
1974年 | 8498篇 |
1973年 | 8141篇 |
1972年 | 7658篇 |
1971年 | 7127篇 |
1970年 | 6878篇 |
1969年 | 6306篇 |
1968年 | 5781篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
I. Fouzas C. Papanikolaou G. Katsanos N. Antoniadis N. Salveridis K. Karakasi S. Vasileiadou A. Fouza E. Mouloudi G. Imvrios V. Papanikolaou 《Transplantation proceedings》2019,51(2):416-420
Aims
Variations of the anatomy of donor hepatic arteries increase the number of arterial anastomoses during liver transplantation and, possibly, the incidence of hepatic artery thrombosis (HAT). In this study, we describe the arterial anatomic variations in liver grafts procured and transplanted by a single center in Greece, the techniques of arterial anastomosis, and their effect on the incidence of early HAT.Materials and Methods
From January 2013 to December 2017, the arterial anatomy of 116 grafts procured for liver transplantation were recorded, as well as the technique of arterial anastomosis and the incidence of early hepatic artery thrombosis (HAT <30 days).Results
A single hepatic artery was recorded in 72.41% of the procured grafts, an aberrant left hepatic artery (accessory or replaced) in 18 grafts (15.52%), and an aberrant right hepatic artery (accessory or replaced) in 17 grafts (14.66%), while other variations were observed in less than 1% of the procured livers. Of the 116 primary liver transplantations, 6 patients (5.17%) developed early HAT <30 days. Two of these patients (1.72%) had 1 anastomosis of the hepatic artery and 4 (3.45%) had 2 anastomoses due to anatomic variations.Conclusions
Anatomic variations of the hepatic artery in liver grafts is a common finding and increase the incidence of early HAT but not to a degree to make these grafts unusable. 相似文献32.
33.
34.
35.
36.
N. V. Bashmakova G. N. Chistiakova I. A. Gazieva Y. M. Trapeznikova D. O. Mazurov 《Gynecological endocrinology》2015,31(10):31-33
AbstractThis study was undertaken to compare the concentrations of pro- and anti-angiogenic growth factors, nitric oxide (NO) stable metabolites in maternal serum and embryonic left ventricular (LV) isovolumic relaxation time (IRT, ms) during the first trimester in two groups of women: with pregnancy conceived by assisted reproductive technologies (ART, n?=?39) and normally conceived (control group, n?=?68) pregnancy. The concentration of vasoconstrictor endothelin 1 was 45.5 times more in ART than in control group. On the contrary, the concentrations of NO stable metabolites in ART were 1.9 times less than in control women. The assessment of angiogenic suppressors in ART women demonstrates the decrease in s-endoglin concentration was 1.6 times and in soluble receptor to vascular endothelial growth factor concentration was 2.0 times in comparison with control group. There was a significant increase in LV IRT in ART embryos in comparison to control ones. These data suggest significant changes in pro- anti-angiogenic factors balance and increase in vascular impedance in ART-conceived embryos. 相似文献
37.
38.
Letter: faecal volatile organic metabolites,promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply 下载免费PDF全文
I. Ahmed R. Greenwood B. Costello N. Ratcliffe C. Probert 《Alimentary pharmacology & therapeutics》2016,43(11):1241-1242
39.
40.
Gregory N. Gan 《Expert opinion on investigational drugs》2016,25(10):1153-1166
Introduction: Cancer treatment is moving away from conventional cytotoxic drugs and towards agents that target specific proteins and mechanisms important to cancer development or survival. The Hedgehog Pathway (HhP) is a signal transduction pathway and its constitutive activation is tumorigenic in basal cell carcinoma (BCC). The HhP enables phenotypic flexibility, and channels tumor-stroma interactions. As a result, it is over-expressed in numerous cancers as well as in the tumor microenvironment and may represent a promising therapeutic target.Areas covered: In this article, we review the rationale for targeting HhP and its role as an oncogenic driver, in tumor epithelial-to-mesenchymal transition (EMT), and in the tumor microenvironment and describe the results of preclinical and clinical studies involving HhP inhibitors.Expert opinion: HhP activation plays an important role in both the tumor microenvironment and tumor EMT which can lead to treatment resistance for a number of different malignancies. In addition to standard use in BCC, several HhP inhibitors are in preclinical, early, and mid-stage clinical development for other solid and hematologic malignancies. 相似文献